Effects of Home-based Respiratory Muscle Training Progamme in Individuals With Ischemic Heart Disease

March 20, 2026 updated by: Ibai López de Uralde Villanueva, Universidad Complutense de Madrid

Effects of Home-based Respiratory Muscle Training by Telerehabilitation on Quality of Life, Cardiopulmonary Function, Physical Status and Psychological Status in Individuals With Ischemic Heart Disease

The main objective of the present study is to verify whether respiratory muscle training programme (IMT+EMT; included both inspriratory and expiratory muscles), applied by telerehabilitation, is an effective intervention (versus placebo and versus inspiratory muscle training in isolation (IMT)) in improving quality of life, cardiopulmonary function and physical and psychological state in people with ischemic heart disease. In addition, the aim is to determine whether respiratory muscle training (IMT or IMT+EMT) is effective in enhancing the results obtained by a conventional cardiac rehabilitation programme on the aforementioned variables.

Study Overview

Study Type

Interventional

Enrollment (Actual)

104

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Madrid, Madrid, Spain, 28040
        • Departamento de Radiología, Rehabilitación y Fisioterapia, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Presence of ischemic heart disease
  • Age 18 years or older
  • Cardiovascular clinical stability

Exclusion Criteria:

  • Any condition that contraindicate exercise training
  • Inability to close the lips to hold the training device's mouthpiece (e.g., facial paralysis)
  • Previous participation in a rehabilitation programme within the last 3 months
  • Pregnancy
  • Inability to adhere to remote monitoring

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Inspiratory muscle training group + Exercise training
Participants in this group will perform a home-based inspiratory muscle training programme (8 weeks) by telerehabilitation and after a center-based conventional cardiovascular exercise programme (8 weeks)
Participants will engage in inspiratory muscle training programme at home using an inspiratory muscle training threshold device . This training will be conducted twice daily, five days a week, for eight weeks, with physiotherapist supervision provided three times per week by telerehabilitation.
Following the respiratory muscle training programme, participants will transition to a center-based cardiovascular exercise programme conducted twice weekly for eight weeks.
Sham Comparator: Inspiratory muscle training sham group + Exercise training
Participants in this group will perform a home-based sham inspiratory muscle training programme (8 weeks) by telerehabilitation and after a center-based conventional cardiovascular exercise programme (8 weeks)
Following the respiratory muscle training programme, participants will transition to a center-based cardiovascular exercise programme conducted twice weekly for eight weeks.
Participants will engage in sham inspiratory muscle training programme at home using a sham inspiratory muscle training threshold device . This training will be conducted twice daily, five days a week, for eight weeks, with physiotherapist supervision provided three times per week by telerehabilitation.
Experimental: Inspiratory and expiratory muscle training group + Exercise training
Participants in this group will perform a home-based inspiratory and expiratory muscle training programme (8 weeks) by telerehabilitation and after a center-based conventional cardiovascular exercise programme (8 weeks)
Following the respiratory muscle training programme, participants will transition to a center-based cardiovascular exercise programme conducted twice weekly for eight weeks.
Participants will engage in inspiratory+expiratory muscle training programme at home using an inspiratory+expiratory muscle training threshold device . This training will be conducted twice daily, five days a week, for eight weeks, with physiotherapist supervision provided three times per week by telerehabilitation.
Sham Comparator: Inspiratory and expiratory muscle training Sham group + Exercise training
Participants in this group will perform a home-based sham inspiratory and expiratory muscle training programme (8 weeks) by telerehabilitation and after a center-based conventional cardiovascular exercise programme (8 weeks)
Following the respiratory muscle training programme, participants will transition to a center-based cardiovascular exercise programme conducted twice weekly for eight weeks.
Participants will engage in sham inspiratory+expiratory muscle training programme at home using a sham inspiratory+expiratory muscle training threshold device . This training will be conducted twice daily, five days a week, for eight weeks, with physiotherapist supervision provided three times per week by telerehabilitation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health related quality of life
Time Frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

EuroQol-five-dimensional Questionnaire A numerical value represented Health state as EQ-5D 'index values' or 'index scores' reflecting how good or bad a health state is.

The VAS is a scale from 0 (worst imaginable health state) to 100 (best imaginable health state).

Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Medical Research Council Dyspnoea Scale
Time Frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
The modified Medical Research Council (mMRC) assess the degree of functional disability due to dyspnoea. The mMRC breathlessness scale ranges from grade 0 to 4. Higher scores mean a worse dyspnoea.
Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Fatigue
Time Frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Multidimensional Fatigue Inventory (MFI-17) The MFI is a valid and reliable instrument for assessing fatigue severity. It consists in 17 items ranked from 1 to 5, the maximun value is 85 points and the minimum 17 points. Higher scores mean a worse fatigue.
Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Cardiopulmonary function: level of exercise capacity
Time Frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

Exercise capacity will be measured using a Cardiopulmonary exercise testing (CPET) that precisely defines maximum exercise capacity through measurement of peak oxygen uptake. The following parameters will be acquired by breath-by-breath analysis using an automated gas analyzer: minute ventilation rate; oxygen consumption (VO2); carbon dioxide production (VCO2); and the other variables of to assess aerobic capacity and to identify potential limiting factors.

An electrocardiogram and blood pressures will be recorded at rest, throughout exercise and during recovery.

Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Strength and endurance of the lower limbs
Time Frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
1 minute sit to stand
Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Upper limb strenght
Time Frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Upper limb muscle strength (handgrip force) will be assessed using a hand-held dynamometer. Three measurements will be performed for each hand, alternating sides, with the elbow at 90° flexion. The best value will be recorded in kilogrames.
Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Respiratory muscle strength
Time Frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Maximal inspiratory preassure and Maximal expiratory preassure
Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Inspiratory muscle endurance
Time Frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Inspiratory muscle endurance will be assed by an incremental load test that required subjects to breathe against inspiratory threshold loads that were increased each minute by 10% of baseline PI,max until voluntary task failure muscle endurance test. Inspiratory muscle endurance was defined as the PI,max sustained for a minimum of 1 min.
Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
Anxiety and depression levels
Time Frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)
The Hospital Anxiety and Depression Scale (HADS) is a self-assessment questionnaire for detecting states of anxiety and depression. The HADS questionnaire has seven items each for depression and anxiety subscales. Scoring for each item ranges from zero to three, with three denoting highest anxiety or depression level.
Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2025

Primary Completion (Actual)

February 6, 2026

Study Completion (Actual)

February 6, 2026

Study Registration Dates

First Submitted

January 20, 2025

First Submitted That Met QC Criteria

February 26, 2025

First Posted (Actual)

March 4, 2025

Study Record Updates

Last Update Posted (Actual)

March 23, 2026

Last Update Submitted That Met QC Criteria

March 20, 2026

Last Verified

June 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ischemic Heart Disease

Clinical Trials on Inspiratory muscle training

Subscribe